BPC-157 in 2026: New FDA Quality Rules and What Compounded Formulations Must Meet
If you follow peptide therapy closely, few topics have generated more confusion in 2026 than the regulatory status of BPC-157. Patients, prescribers, and compounding pharmacies have all faced shifting guidance from the FDA, conflicting information online, and genuine uncertainty about what is currently legal, what is safe, and what comes next. This article cuts through […]